Katrin E. Rhodes

1.8k total citations
21 papers, 1.3k citations indexed

About

Katrin E. Rhodes is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Katrin E. Rhodes has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Katrin E. Rhodes's work include Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (6 papers) and Zebrafish Biomedical Research Applications (5 papers). Katrin E. Rhodes is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (6 papers) and Zebrafish Biomedical Research Applications (5 papers). Katrin E. Rhodes collaborates with scholars based in United States, Vietnam and Canada. Katrin E. Rhodes's co-authors include Hanna Mikkola, Dongyun Yang, Heinz‐Josef Lenz, Christos Gekas, Oliver W. Press, Michael A. Gordon, Daniel Vallböhmer, Susan Groshen, Wu Zhang and Syma Iqbal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Katrin E. Rhodes

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrin E. Rhodes United States 13 575 560 314 214 204 21 1.3k
Kenneth R. Shroyer United States 22 860 1.5× 350 0.6× 210 0.7× 260 1.2× 132 0.6× 33 1.5k
Francesco Atzori Italy 13 776 1.3× 435 0.8× 270 0.9× 145 0.7× 105 0.5× 62 1.4k
Yanli Su United States 15 790 1.4× 472 0.8× 198 0.6× 127 0.6× 159 0.8× 22 1.4k
Shingo Akimoto Japan 22 1.4k 2.4× 391 0.7× 255 0.8× 158 0.7× 224 1.1× 37 1.8k
Yan Aalto Finland 17 560 1.0× 368 0.7× 224 0.7× 89 0.4× 80 0.4× 25 1.2k
H Sakamoto Japan 18 1.0k 1.8× 434 0.8× 220 0.7× 183 0.9× 205 1.0× 32 1.5k
Huiying Piao United States 10 715 1.2× 442 0.8× 198 0.6× 125 0.6× 51 0.3× 10 1.2k
Angela Celetti Italy 27 1.0k 1.7× 561 1.0× 260 0.8× 93 0.4× 99 0.5× 44 1.5k
Leonardo Faoro United States 16 686 1.2× 691 1.2× 344 1.1× 248 1.2× 85 0.4× 36 1.6k
Daniel Wai United States 22 945 1.6× 514 0.9× 616 2.0× 96 0.4× 126 0.6× 42 1.7k

Countries citing papers authored by Katrin E. Rhodes

Since Specialization
Citations

This map shows the geographic impact of Katrin E. Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin E. Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin E. Rhodes more than expected).

Fields of papers citing papers by Katrin E. Rhodes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin E. Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin E. Rhodes. The network helps show where Katrin E. Rhodes may publish in the future.

Co-authorship network of co-authors of Katrin E. Rhodes

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin E. Rhodes. A scholar is included among the top collaborators of Katrin E. Rhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin E. Rhodes. Katrin E. Rhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gekas, Christos, et al.. (2010). Hematopoietic stem cell development in the placenta. The International Journal of Developmental Biology. 54(6-7). 1089–1098. 47 indexed citations
2.
Gekas, Christos, Katrin E. Rhodes, Hildur Helgadóttir, et al.. (2009). Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. Blood. 113(15). 3461–3471. 44 indexed citations
3.
Schultheis, Anne M., Georg Lurje, Katrin E. Rhodes, et al.. (2008). Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab. Clinical Cancer Research. 14(22). 7554–7563. 137 indexed citations
4.
Rhodes, Katrin E., Christos Gekas, Yanling Wang, et al.. (2008). The Emergence of Hematopoietic Stem Cells Is Initiated in the Placental Vasculature in the Absence of Circulation. Cell stem cell. 2(3). 252–263. 225 indexed citations
5.
Gekas, Christos, Katrin E. Rhodes, & Hanna Mikkola. (2008). Isolation and Analysis of Hematopoietic Stem Cells from the Placenta. Journal of Visualized Experiments. 3 indexed citations
6.
Gekas, Christos, Katrin E. Rhodes, & Hanna Mikkola. (2008). Isolation and Analysis of Hematopoietic Stem Cells from the Placenta. Journal of Visualized Experiments. 6 indexed citations
7.
Schenke‐Layland, Katja, Katrin E. Rhodes, Ekaterini Angelis, et al.. (2008). Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages. Stem Cells. 26(6). 1537–1546. 176 indexed citations
8.
Rhodes, Katrin E., Wu Zhang, Dongyun Yang, et al.. (2007). ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan. Drug Metabolism Letters. 1(1). 23–30. 36 indexed citations
9.
Schenke‐Layland, Katja, Ekaterini Angelis, Katrin E. Rhodes, et al.. (2007). Collagen IV Induces Trophoectoderm Differentiation of Mouse Embryonic Stem Cells. Stem Cells. 25(6). 1529–1538. 83 indexed citations
10.
Zhang, Wu, Michael A. Gordon, Oliver W. Press, et al.. (2006). Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab. Pharmacogenetics and Genomics. 16(7). 475–483. 101 indexed citations
11.
Vallböhmer, Daniel, Syma Iqbal, Dongyun Yang, et al.. (2006). Molecular determinants of irinotecan efficacy. International Journal of Cancer. 119(10). 2435–2442. 52 indexed citations
12.
Zhang, Wu, Jan Stoehlmacher, Jae‐Hyun Park, et al.. (2005). Gene Polymorphisms of Epidermal Growth Factor Receptor and its Downstream Effector, Interleukin-8, Predict Oxaliplatin Efficacy in Patients with Advanced Colorectal Cancer. Clinical Colorectal Cancer. 5(2). 124–131. 58 indexed citations
13.
Vallböhmer, Daniel, Dongyun Yang, Jeong H. Yun, et al.. (2005). Genomic profile associated with clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with epidermal growth factor receptor (EGFR) inhibitor cetuximab. Journal of Clinical Oncology. 23(16_suppl). 3557–3557. 2 indexed citations
14.
Gordon, Michael A., Bo Lü, Wu Zhang, et al.. (2005). Genomic Profiling Associated with Recurrence in Patients with Rectal Cancer Treated with Chemoradiation. Pharmacogenomics. 7(1). 67–88. 44 indexed citations
15.
Vallböhmer, Daniel, Michael A. Gordon, Dongyun Yang, et al.. (2005). Molecular determinants of cetuximab efficacy. Journal of Clinical Oncology. 23(16_suppl). 3551–3551. 7 indexed citations
16.
Vallböhmer, Daniel, Wu Zhang, Michael A. Gordon, et al.. (2005). Molecular Determinants of Cetuximab Efficacy. Journal of Clinical Oncology. 23(15). 3536–3544. 192 indexed citations
17.
Press, Oliver W., David Y. Yang, Jun-Won Yun, et al.. (2005). Gender related survival differences associated with polymorphic variants of estrogen receptor beta (ERβ) and epidermal growth fact receptor (EGFR) in patients with metastatic colon cancer. Journal of Clinical Oncology. 23(16_suppl). 3590–3590. 1 indexed citations
18.
Yang, Dongyun, Daniel Vallböhmer, Katrin E. Rhodes, et al.. (2005). Molecular prognostic factors of irinotecan efficacy. Journal of Clinical Oncology. 23(16_suppl). 3621–3621. 3 indexed citations
19.
Rhodes, Katrin E., Daniel Vallböhmer, Dongyun Yang, et al.. (2005). Molecular predictor of irinotecan (CPT-11) efficacy. Journal of Clinical Oncology. 23(16_suppl). 3560–3560. 1 indexed citations
20.
Zhang, Wu, Jae‐Hyun Park, Bo Lü, et al.. (2005). Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation. Clinical Cancer Research. 11(2). 600–605. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth R. Shroyer Breakdown of academic impact, for papers by Francesco Atzori Breakdown of academic impact, for papers by Yanli Su Breakdown of academic impact, for papers by Shingo Akimoto Breakdown of academic impact, for papers by Yan Aalto Breakdown of academic impact, for papers by H Sakamoto Breakdown of academic impact, for papers by Huiying Piao Breakdown of academic impact, for papers by Angela Celetti Breakdown of academic impact, for papers by Leonardo Faoro Breakdown of academic impact, for papers by Daniel Wai
Rankless by CCL
2026